Travere Therapeutics to Report First Quarter 2026 Financial Results
Go back to Travere Therapeutics to Report First Quarter 2026 Financial Results| (NASDAQ: TVTX) | Delayed: 66.17 -1.34 (1.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $67.51 | 52 Week High | $ | |||
| Open | $67.76 | 52 Week Low | $ | |||
| Day High | $68.73 | P/E | N/A | |||
| Day Low | $66.11 | EPS | $ | |||
| Volume | 1,149,753 | |||||

